Can vitamin c boost chemo against rare cancers?
NCT ID NCT04634227
First seen May 23, 2026 · Last updated May 23, 2026
Summary
This early-stage study tests whether adding high-dose vitamin C to a standard chemotherapy drug (gemcitabine) can help control advanced soft tissue or bone sarcomas that cannot be removed by surgery or have spread. About 30 adults will receive the combination intravenously. The main goal is to see how many patients have stable disease or better after 12 weeks of treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
John
Iowa City, Iowa, 52242, United States
Conditions
Explore the condition pages connected to this study.